Vanguard Portfolio Management
DNA icon

Vanguard Portfolio Management’s Ginkgo Bioworks DNA Stock Holding History

Vanguard Portfolio Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.29M Buy
937,803
+372,151
+66% +$3.11M ﹤0.01% 2219
2026
Q1 		$3.47M Buy
+565,652
New +$4.71M ﹤0.01% 2436

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management's DNA Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Ginkgo Bioworks (DNA) stake by 66% in Q2 2026, buying an estimated $3.11M and bringing the position to 937,803 shares worth $9.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2219.

Vanguard Portfolio Management first reported a position in DNA in Q1 2026 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Vanguard Portfolio Management held 937,803 shares of Ginkgo Bioworks worth $9.29M as of Q2 2026.
  • Vanguard Portfolio Management bought 372,151 Ginkgo Bioworks shares in Q2 2026, an estimated $3.11M.
  • Ginkgo Bioworks made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2219 holding.
  • Vanguard Portfolio Management first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 2 quarters since.
  • 167 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.